CC Chemours Co
company
SEC Filings & Insider Trading Activity 2026

CIK: 1627223
Health Care
Chemicals & Allied Products 48 filings
Russell 2000

Latest Chemours Co (CC) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on April 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Chemours Co (CC) (SEC CIK 1627223), with AI-powered section-by-section summaries updated daily.

10-Q: 32
10-K: 11
8-K: 5

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 24, 2026
10-Q Quarterly Report
Nov 6, 2025
8-K Current Report
Apr 30, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Business Overview

  • Core business: global provider of performance chemicals serving diverse industries via three segments—Thermal & Specialized Solutions, Titanium Technologies, Advanced Performance Materials
  • New strategy "Pathway to Thrive" launched in 2024 focusing on operational excellence, growth in data center cooling, next-gen refrigerants, and semiconductor fabrication
+3 more insights

Risk Factors

  • Litigation risk: $270 million settlement charge with State of New Jersey for environmental litigation in 2025
  • Geopolitical risk: Sale of Taiwan Titanium site for $360 million pending local regulatory and environmental approvals, mid-2026
+3 more insights

Management Discussion & Analysis

  • Revenue $5.758B, down 2% YoY; Thermal & Specialized Solutions up $236M (13%) to $2.1B, Titanium Technologies down $143M (6%) to $2.4B, Advanced Performance Materials down $63M (5%) to $1.3B
  • Profitability: Thermal & Specialized Solutions Adj. EBITDA margin 32% vs 31%, Titanium Technologies margin 6% vs 12%, Advanced Performance Materials margin 9% vs 12%
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • Newly added environmental compliance risk triggered by evolving U.S. and international laws including CERCLA, TSCA, EU REACH, and China MEE Order No. 12
  • Updated environmental remediation costs risk with accrual uncertainties due to site complexity, contamination extent, and PRP outcomes
Read full Q3 2025 10-Q analysis →

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Mar 12, 2026
8-K
Full analysis →

Item 8.01: Other Events

  • $700M in 7.875% Senior Notes due 2034 closed Mar 12, 2026 — rate significantly higher than the notes being retired
  • Proceeds used to redeem $188M of 5.750% notes due 2028 (~$189.8M total) and ~$500.3M of 5.375% notes due 2027
Filed Feb 26, 2026
8-K
Full analysis →

Item 8.01: Other Events

  • $700M senior unsecured notes at 7.875% due 2034, priced in private offering exempt from Securities Act registration
  • Deal upsized by $100M from initial $600M target — strong investor demand signal

Annual Reports Archive
10-K

AI-powered analysis of Chemours Co (CC) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of Chemours Co (CC) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of Chemours Co (CC) 8-K current reports disclosing material events.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$6.8B$6.0B$5.8B$5.8B
Gross Profit$1.6B$1.3B$1.2B$902.0M
Net Income$578.0M-$238.0M$86.0M-$386.0M
Gross Margin23.8%21.7%19.9%15.5%
Net Margin8.5%-3.9%1.5%-6.6%
Balance Sheet
Total Assets$7.6B$8.3B$7.5B$7.4B
Equity$1.1B$737.0M$604.0M$250.0M
ROE52.2%-32.3%14.2%-154.4%

Source: XBRL financial data from Chemours Co (CC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 30, 2026
8-K
Mar 12, 2026Analysis
8-K
Feb 26, 2026Analysis
10-K
Feb 24, 2026Dec 31, 2025Analysis
8-K
Feb 19, 2026
8-K
Jan 16, 2026
10-Q
Nov 6, 2025Sep 30, 2025Analysis
10-Q
Aug 5, 2025Jun 30, 2025
10-Q
May 6, 2025Mar 31, 2025
10-K
Feb 18, 2025Dec 31, 2024
10-Q
Nov 4, 2024Sep 30, 2024
10-Q
Aug 1, 2024Jun 30, 2024
10-Q
Apr 30, 2024Mar 31, 2024
10-K
Mar 27, 2024Dec 31, 2023
10-Q
Oct 27, 2023Sep 30, 2023
10-Q
Jul 28, 2023Jun 30, 2023
10-Q
Apr 28, 2023Mar 31, 2023
10-K
Feb 10, 2023Dec 31, 2022
10-Q
Oct 26, 2022Sep 30, 2022
10-Q
Aug 1, 2022Jun 30, 2022
10-Q
May 3, 2022Mar 31, 2022
10-K
Feb 11, 2022Dec 31, 2021
10-Q
Nov 5, 2021Sep 30, 2021
10-Q
Jul 30, 2021Jun 30, 2021
10-Q
May 5, 2021Mar 31, 2021

Frequently Asked Questions

What are the latest CC SEC filings in 2026?

Chemours Co (CC) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on April 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did CC file its most recent 10-K annual report?

Chemours Co (CC) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view CC 10-Q quarterly reports?

Chemours Co (CC)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every CC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has CC filed recently?

Chemours Co (CC)'s most recent 8-K was filed on April 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find CC insider trading activity (Form 4)?

SignalX aggregates every CC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does CC file with the SEC?

Chemours Co (CC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CC filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Chemours Co (CC).

What is CC's SEC CIK number?

Chemours Co (CC)'s SEC CIK (Central Index Key) number is 1627223. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1627223 to look up all CC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find CC return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Chemours Co (CC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Chemours Co SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 48+ filings.